Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma

Acta Neuropathologica

Volumn 118, Issue 3, 2009, Pages 401-405

  Korshunov, Andrey ^a,b   Meyer, Jochen ^b   Capper, David ^a   Christians, Arne ^b   Remke, Marc ^b   Witt, Hendrik ^b   Pfister, Stefan ^a,b   von Deimling, Andreas ^a,b   Hartmann, Christian ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

BRAF; Diffuse astrocytoma; IDH1; IDH2; Pilocytic astrocytoma

Indexed keywords

B RAF KINASE; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE ISOENZYME; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CHILD; DIFFERENTIAL DIAGNOSIS; DIFFUSE ASTROCYTOMA; DISEASE CLASSIFICATION; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; ISOCITRATE DEHYDROGENASE; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 68349088073     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-009-0550-z     Document Type: Article

References (18)

1. Balss J, Meyer J, Mueller W et al (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116:597-602
2. Bar EE, Lin A, Tihan T et al (2008) Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 67:878-887
3. Forshew T, Tatevossian RG, Lawson AR et al (2009) Activation of the ERK/ MAPK pathway: A signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol 218:172-181
4. Hayne C, Tzivion G, Luo Z (2000) Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole. J Biol Chem 275:31876-31882
5. Hayostek CJ, Shaw EG, Scheithauer B et al (1993) Astrocytomas of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer 72:856-869
6. Ichimura K, Pearson DM, Kocialkowski S et al (2009) IDH1 mutations are present in the majority of common adult gliomas but are rare in primary glioblastomas. Neuro Oncol (epub ahead of print)
7. Jones DT, Kocialkowski S, Liu L et al (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673-8677
8. Jones DT, Kocialkowski S, Liu L et al (2009) Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene (epub ahead of print)
9. Kruchko C, Brem S, Lee H et al (2008) Statistical report: Primary brain tumors in the United States, 2000-2004, Hinsdale: Central Brain Tumor Registry of the United States (CBTRUS)
10. Lee SM, Koh HJ, Park DC et al (2002) Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 32:1185-1196
11. Louis DN et al (2007) WHO classification of tumours of the central nervous system, 4th edn. World Health Organization classification of tumours. International Agency for Research on Cancer, Lyon
12. Palma L, Russo A, Celli P (1984) Prognosis of the so-called "diffuse" cerebellar astrocytoma. Neurosurgery 15:315-317
13. Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812
14. Pfister S, Janzarik WG, Remke M et al (2008) BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118:1739-1749
15. Sievert AJ, Jackson EM, Gai X et al (2009) Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol (epub ahead of print)
16. Watanabe T, Nobusawa S, Kleihues P et al (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149-1153
17. Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773
18. Zhao S, Lin Y, Xu W et al (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324:261-265